Nvidia adds a record $150bn to its share buyback

Nvidia approved an additional $150 billion share-repurchase authorization, lifting its remaining buyback capacity to $235 billion through fiscal 2028. The company described the increase as the largest share-repurchase authorization expansion in history and said it reflects confidence in its long-term growth opportunity. The authorization provides substantial prospective support for EPS and shareholder returns.

Analysis

The authorization is principally a floor under NVDA’s valuation rather than incremental operating upside: at a ~$4T equity value, even full deployment of the remaining capacity over roughly 2.5 years would retire only mid-single-digit percentage share count before considering stock-based compensation. Its greater signaling value is that management sees internally generated cash materially exceeding near-term capex, working-capital, and strategic-investment needs. That shifts the debate from whether AI infrastructure demand is real to whether NVDA can sustain enough FCF to fund both supply-chain expansion and shareholder returns without impairing its technology lead.

Near term, the announcement can tighten downside liquidity and support a momentum re-rating, particularly if quarterly execution remains clean. Over the next 1-3 months, the key catalyst is whether gross margin and backlog commentary validate that product-transition costs are temporary; a buyback cannot offset a material hyperscaler digestion signal. Watch repurchase execution in the cash-flow statement rather than authorization headlines, as accelerated buying near elevated multiples would be a weak capital-allocation signal and leave less flexibility for ecosystem investments.

The non-obvious beneficiary is the AI stack’s valuation umbrella: sustained NVDA cash generation makes customers’ accelerator roadmaps and suppliers’ capacity plans appear more durable, supporting TSM, AVGO and ANET. But this also raises the hurdle for peers: AMD and INTC must compete against a leader able to fund R&D, software incentives, supply commitments and repurchases simultaneously. Contrarian view: consensus may overvalue the authorization’s per-share impact; if the stock advances materially on this alone, the risk/reward deteriorates absent upward FCF revisions.

Key Decisions for Investors

• Maintain/enter NVDA only on post-event consolidation rather than chase authorization-driven strength; target a 3-6 month holding period, with the thesis dependent on continued data-center revenue growth and stable gross-margin guidance. Reduce if management signals demand digestion or if quarterly repurchases are immaterial relative to stated capacity.
• Pair long NVDA versus short AMD over 3-6 months: NVDA’s balance-sheet capacity compounds its platform advantage while AMD remains more exposed to needing share gains to justify AI expectations. Size modestly; cover the short if AMD shows sustained MI-series supply expansion and AI revenue guidance materially above consensus.
• Use TSM as a lower-beta AI-capex expression over 6-12 months rather than treating the buyback as an isolated NVDA catalyst. Falsification is a meaningful cut in leading-edge wafer demand or evidence that NVDA shifts supply allocation away from TSM.
• Monitor NVDA’s next cash-flow statement for actual buyback pace, stock-based-compensation dilution, capex commitments and net cash. Treat a large headline authorization without corresponding execution or FCF growth as neutral, not a reason to add risk.